Erich A. Leeser

Array ( [id] => 3409575 [patent_doc_number] => 05460947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas' [patent_app_type] => 1 [patent_app_number] => 8/219963 [patent_app_country] => US [patent_app_date] => 1994-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 18261 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/460/05460947.pdf [firstpage_image] =>[orig_patent_app_number] => 219963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690183 [patent_doc_number] => 05604107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Detection of neu p185 in cell lysates' [patent_app_type] => 1 [patent_app_number] => 8/220962 [patent_app_country] => US [patent_app_date] => 1994-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 12760 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604107.pdf [firstpage_image] =>[orig_patent_app_number] => 220962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516618 [patent_doc_number] => 05486456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-23 [patent_title] => 'Method of diagnosing ovarian, endometrial, and colon cancers with monoclonal antibodies OXA and OXB' [patent_app_type] => 1 [patent_app_number] => 8/216616 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10407 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/486/05486456.pdf [firstpage_image] =>[orig_patent_app_number] => 216616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699311 [patent_doc_number] => 05646003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Preimplantation factor' [patent_app_type] => 1 [patent_app_number] => 8/216618 [patent_app_country] => US [patent_app_date] => 1994-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646003.pdf [firstpage_image] =>[orig_patent_app_number] => 216618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617218 [patent_doc_number] => 05641486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Methods for inhibiting transcription of the cyclic AMP responsive element binding protein and the activating transcription factor 1' [patent_app_type] => 1 [patent_app_number] => 8/210880 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 6269 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641486.pdf [firstpage_image] =>[orig_patent_app_number] => 210880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656841 [patent_doc_number] => 05627039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Mortalin and methods for determining complementation group assignment of cancer cells' [patent_app_type] => 1 [patent_app_number] => 8/214583 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 10907 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627039.pdf [firstpage_image] =>[orig_patent_app_number] => 214583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697879 [patent_doc_number] => 05596081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics' [patent_app_type] => 1 [patent_app_number] => 8/208822 [patent_app_country] => US [patent_app_date] => 1994-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 10511 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596081.pdf [firstpage_image] =>[orig_patent_app_number] => 208822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623054 [patent_doc_number] => 05686072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Epitope-specific monoclonal antibodies and immunotoxins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/202042 [patent_app_country] => US [patent_app_date] => 1994-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 21995 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686072.pdf [firstpage_image] =>[orig_patent_app_number] => 202042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516613 [patent_doc_number] => 05506109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Vitamin B12 assay' [patent_app_type] => 1 [patent_app_number] => 8/198012 [patent_app_country] => US [patent_app_date] => 1994-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/506/05506109.pdf [firstpage_image] =>[orig_patent_app_number] => 198012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699296 [patent_doc_number] => 05646002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Method for increasing the sensitivity of assays for target ligand' [patent_app_type] => 1 [patent_app_number] => 8/195987 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6577 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646002.pdf [firstpage_image] =>[orig_patent_app_number] => 195987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585347 [patent_doc_number] => 05552291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Anti-human pulmonary adenocarcinoma specific monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 8/194633 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6801 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552291.pdf [firstpage_image] =>[orig_patent_app_number] => 194633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3546017 [patent_doc_number] => 05545532 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging' [patent_app_type] => 1 [patent_app_number] => 8/192840 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 9580 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545532.pdf [firstpage_image] =>[orig_patent_app_number] => 192840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101338 [patent_doc_number] => 05447840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'Receptor of the small rhinovirus receptor group' [patent_app_type] => 1 [patent_app_number] => 8/182824 [patent_app_country] => US [patent_app_date] => 1994-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7190 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447840.pdf [firstpage_image] =>[orig_patent_app_number] => 182824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697085 [patent_doc_number] => 05674493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/176218 [patent_app_country] => US [patent_app_date] => 1993-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4849 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674493.pdf [firstpage_image] =>[orig_patent_app_number] => 176218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552035 [patent_doc_number] => 05518882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Immunological methods of component selection and recovery' [patent_app_type] => 1 [patent_app_number] => 8/172133 [patent_app_country] => US [patent_app_date] => 1993-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7156 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/518/05518882.pdf [firstpage_image] =>[orig_patent_app_number] => 172133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3486390 [patent_doc_number] => 05474899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Selective immunoassay for IL-1 .beta.' [patent_app_type] => 1 [patent_app_number] => 8/164283 [patent_app_country] => US [patent_app_date] => 1993-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6805 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474899.pdf [firstpage_image] =>[orig_patent_app_number] => 164283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586559 [patent_doc_number] => 05516643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Immunochemical assays for cancer-associated SCM-recognition factor' [patent_app_type] => 1 [patent_app_number] => 8/161176 [patent_app_country] => US [patent_app_date] => 1993-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 19945 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516643.pdf [firstpage_image] =>[orig_patent_app_number] => 161176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3566550 [patent_doc_number] => 05484735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids' [patent_app_type] => 1 [patent_app_number] => 8/151073 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 32 [patent_no_of_words] => 21319 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484735.pdf [firstpage_image] =>[orig_patent_app_number] => 151073 [rel_patent_id] =>[rel_patent_doc_number] =>)